Chuck Royce's position in Neogenomics is currently worth $6.91 Million. That's 0.08% of their equity portfolio (353rd largest holding). The investor owns 3.33% of the outstanding Neogenomics stock. The first Neogenomics trade was made in Q4 2015. Since then Chuck Royce bought shares fifteen more times and sold shares on sixteen occasions. The investor's estimated purchase price is $9.79 Million, resulting in a loss of 29%.